Your browser doesn't support javascript.
loading
Standards for clinical trials for treating TB.
du Cros, P; Greig, J; Alffenaar, J-W C; Cross, G B; Cousins, C; Berry, C; Khan, U; Phillips, P P J; Velásquez, G E; Furin, J; Spigelman, M; Denholm, J T; Thi, S S; Tiberi, S; Huang, G K L; Marks, G B; Turkova, A; Guglielmetti, L; Chew, K L; Nguyen, H T; Ong, C W M; Brigden, G; Singh, K P; Motta, I; Lange, C; Seddon, J A; Nyang'wa, B-T; Maug, A K J; Gler, M T; Dooley, K E; Quelapio, M; Tsogt, B; Menzies, D; Cox, V; Upton, C M; Skrahina, A; McKenna, L; Horsburgh, C R; Dheda, K; Marais, B J.
Afiliación
  • du Cros P; Burnet Institute, Melbourne, VIC, Monash Infectious Diseases, Monash Health, Melbourne, VIC, Australia.
  • Greig J; Burnet Institute, Melbourne, VIC, Médecins Sans Frontières (MSF), Manson Unit, London, UK.
  • Alffenaar JC; Sydney Infectious Diseases Institute (Sydney ID), and, School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Westmead Hospital, Sydney, NSW.
  • Cross GB; Burnet Institute, Melbourne, VIC, Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
  • Cousins C; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Berry C; Médecins Sans Frontières (MSF), Manson Unit, London, UK.
  • Khan U; Interactive Research and Development Global, Singapore City, Singapore.
  • Phillips PPJ; UCSF Center for Tuberculosis, Division of Pulmonary and Critical Care Medicine, and.
  • Velásquez GE; UCSF Center for Tuberculosis, Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA.
  • Furin J; Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA.
  • Spigelman M; Global Alliance for TB Drug Development, New York, NY, USA.
  • Denholm JT; Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC, Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
  • Thi SS; Eswatini National TB Control Program, Mbabane, Kingdom of Eswatini.
  • Tiberi S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, GlaxoSmithKline, London, UK.
  • Huang GKL; Burnet Institute, Melbourne, VIC, Northern Health Infectious Diseases, Northern Health, Melbourne, VIC.
  • Marks GB; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Turkova A; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Guglielmetti L; Médecins Sans Frontières (MSF), Paris, Sorbonne Université, Institut national de la santé et de la recherche médicale, Unité 1135, Centre d'Immunologie et des Maladies Infectieuses, Paris, Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pit
  • Chew KL; Department of Laboratory Medicine, National University Hospital, Singapore City, Singapore.
  • Nguyen HT; Research Department, Friends for International TB Relief, Ha Noi, Vietnam.
  • Ong CWM; Infectious Diseases Translational Research Programme, Department of Medicine, National University of Singapore, Singapore City, Division of Infectious Diseases, Department of Medicine, National University Hospital, Singapore City, Institute of Healthcare Innovation & Technology, National Univers
  • Brigden G; The Global Fund, Geneva, Switzerland.
  • Singh KP; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia, Victorian Infectious Disease Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Motta I; MSF, Geneva, Switzerland.
  • Lange C; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, German Center for Infection Research (DZIF), TTU-TB, Borstel, Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA
  • Seddon JA; Department of Infectious Disease, Imperial College London, London, UK, Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, South Africa.
  • Nyang'wa BT; Public Health Department, Operational Center Amsterdam (OCA), MSF, Amsterdam, The Netherlands.
  • Maug AKJ; Damien Foundation Bangladesh, Dhaka, Bangladesh.
  • Gler MT; De La Salle Medical and Health Sciences Institute, Dasmariñas, the Philippines.
  • Dooley KE; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Quelapio M; Tropical Disease Foundation, Makati City, Manila, the Philippines, KNCV Tuberculosis Foundation, The Hague, The Netherlands.
  • Tsogt B; Mongolian Anti-TB Coalition, Ulaanbaatar, Mongolia.
  • Menzies D; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute & McGill International TB Centre, Montreal, QC, Canada.
  • Cox V; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town.
  • Upton CM; TASK Applied Science, Cape Town, South Africa.
  • Skrahina A; The Republican Scientific and Practical Center for Pulmonology and TB, Minsk, Belarus.
  • McKenna L; Treatment Action Group, New York, NY.
  • Horsburgh CR; Departments of Global Health, Epidemiology, Biostatistics and Medicine, Schools of Public Health and Medicine, Boston University, Boston MA, USA.
  • Dheda K; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa, Faculty of Infectious and Tropical Diseases, Department of Im
  • Marais BJ; Sydney Infectious Diseases Institute (Sydney ID), and, The Children's Hospital at Westmead, Sydney, NSW, WHO Collaborating Centre in Tuberculosis, The University of Sydney, Sydney, NSW, Australia.
Int J Tuberc Lung Dis ; 27(12): 885-898, 2023 Dec 01.
Article en En | MEDLINE | ID: mdl-38042969
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Francia